Search clinical trials for: Placebo for Hepar-P

Total 3639 results

Nova Laboratories Sdn Bhd

Unknown

Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease (Hepar-P)

Non-alcoholic Fatty Liver Disease

Malaysia
Simon Fraser University

Completed

Cardiovascular Effects of Aerosols in Residences Study (CLEAR)

Endothelial Dysfunction | Systemic Inflammation

Canada
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Randomized Trial to Reduce Environmental Tobacco Smoke in Children With Asthma

Lung Diseases | Asthma
Parion Sciences

Completed

An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness

Sjogren's Syndrome | Xerostomia

United States
University of Rochester
National Institute of Nursing Research (NINR); National Institute of Neurological... and other collaborators

Completed

Treatment of Insomnia Secondary to Chronic Pain

Pain | Insomnia

United States
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections

Acute Upper Respiratory Infections

Russian Federation
Pfizer

Completed

A Study to Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

COVID-19

Spain, United States, Australia, Canada, Bulgaria, Slovakia, Mexico, Hungary, Brazil
University of Manitoba

Completed

Impact of Cognitive Behavioral Therapy on Parasomnias (parasomnia)

Parasomnia

Canada
Iowa State University

Enrolling by invitation

A Randomized Controlled Trial of ACT-P Versus T4C for Community Reentry

Violence | Criminal Behavior

United States
University of Florida
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Sleep and Pain Interventions in Fibromyalgia (SPIN)

Insomnia | Fibromyalgia

United States
Merck Sharp & Dohme LLC

Completed

A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)

HIV Infections
EnnovaBio Australia Pharmaceuticals Pty Ltd

Not yet recruiting

A First-in-Human SAD/MAD Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ENC1018 in Healthy Adult Subjects

Healthy
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of IBI356 in Healthy Participants and in Atopic Dermatitis Patients

Healthy Participants | Atopic Dermatitis Patients

China
University of Pittsburgh

Completed

RAPID: Reducing Pain; Preventing Depression (RAPID)

Knee Osteoarthritis

United States
St. Antonius Hospital

Terminated

Bloodtranfusions After Aortic Surgery (FIBTEG)

Hemorrhage | Thoracic Aneurysm

Netherlands
ZYUS Life Sciences Inc.
Novotech (Australia) Pty Limited; ZYUS Life Sciences Australia Pty Ltd

Completed

Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation (HOPE)

Healthy | Osteoarthritis

Australia
China Medical University Hospital
Ministry of Science and Technology, Taiwan

Recruiting

Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder

Parkinson's Disease With Dementia

Taiwan
Arizona State University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

Cognitive Behavioral Therapy Treatments for Adults With Rheumatoid Arthritis (The SARA Study)

Rheumatoid Arthritis

United States
Pfizer

Completed

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

COVID-19

United States, Russian Federation, Thailand, Czechia, Colombia, Bulgaria, Japan, South Africa, Turkey, Argentina, Hungary, Malaysia, Mexico, Poland, Spain, Ukraine, Brazil
AbbVie

Completed

Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1

HCV Infection

United States
Parion Sciences

Terminated

Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Theravance Biopharma

Completed

SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects

Healthy

United States
Chong Kun Dang Pharmaceutical

Recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia

Korea, Republic of
Spero Therapeutics
Simbec Research

Completed

A Study of the Safety, Tolerability, and Pharmacokinetics of SPR720 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Abbott

Completed

Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

HCV Infection

United States
NYU Langone Health
National Institute of Mental Health (NIMH)

Recruiting

Adolescent Digital Mental Health-Kenya Effectiveness

Mental Disorder in Adolescence

Kenya
Hebrew University of Jerusalem

Unknown

Personalized Inhibitory Control Training for Compulsive Behavior Change

OCD

Israel
Hanmi Pharmaceutical Company Limited

Completed

Trial to Evaluate the Efficacy and Safety of HCP1302

Hypertension | Erectile Dysfunction
University of Rochester
National Institute of Mental Health (NIMH)

Completed

Psychosocial Treatment for Women With Depression and Pain

Depression | Pelvic Pain

United States
AstraZeneca

Completed

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

Chronic Pain

Germany, Sweden, United Kingdom
Parion Sciences

Terminated

Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Parion Sciences

Completed

Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Eli Lilly and Company
OPKO Health, Inc.

Completed

A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of Diabetes

Diabetes Mellitus, Type 2

United States, Puerto Rico
Sonova AG
Hearts for Hearing

Completed

Optimizing Soft Speech Recognition in Children With Hearing Loss (SoftSpeech)

Hearing Loss, Sensorineural | Hearing Loss, Bilateral

United States
VA Office of Research and Development

Completed

Ending Self Stigma for PTSD (ESS-P)

Post Traumatic Stress Disorder

United States
Elixir Pharmaceuticals

Completed

Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil

Type 2 Diabetes Mellitus
Novartis Pharmaceuticals

Completed

A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH) (ORION-5)

Homozygous Familial Hypercholesterolemia

Hong Kong, Israel, Russian Federation, Serbia, South Africa, Taiwan, Turkey, Ukraine
Vivozon, Inc.

Completed

Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection (P1_VVZ149IV)

Healthy

Korea, Republic of
University Hospital, Geneva
University Hospital, Basel, Switzerland; University of Lausanne Hospitals; University... and other collaborators

Unknown

Patient Preference, Sleep Quality, and Anxiety/Depression: A Comparison of Raltegravir and Efavirenz (Switch-ER)

HIV Infections | Sleep Disorders

Switzerland
University of Surrey

Completed

Intra-individual Real Life Effects of Cocoa Flavanols on Blood Pressure and Arterial Stiffness

Sleep | Blood Pressure | Stiffness, Vascular

United Kingdom
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Limited-stage Small Cell Lung Cancer (LS-SCLC)

China, France, United States, Spain, Taiwan, Korea, Republic of, Turkey, Italy, Netherlands, Georgia, Germany, Belgium, Poland, Romania
Vivozon, Inc.

Completed

A Single Ascending Dose Escalation to Investigate Safety and PK of VVZ-149 Injection in Healthy Older Male Volunteers

Healthy
Centers for Disease Control and Prevention
British Medical Research Council

Recruiting

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI (ASTERoiD)

Latent Tuberculosis

Australia, United States, Canada, South Africa
Hoffmann-La Roche

Completed

A Study With RO4917523 in Patients With Fragile X Syndrome

Fragile X Syndrome

United States
University of Florida

Completed

Effect of Armodafinil on Simulated Driving

Healthy Volunteers

United States
Agios Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Mitapivat (AG-348) in Healthy Adult Participants

Healthy Volunteers

United States
Ahn-Gook Pharmaceuticals Co.,Ltd
Samsung Medical Center; Seoul St. Mary's Hospital; Seoul National University... and other collaborators

Completed

Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

Allergic Rhinitis | Perennial Allergic Rhinitis | Non-seasonal Allergic Rhinitis

Korea, Republic of
Penn State University
Reliant Pharmaceuticals

Completed

Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides (OMEGA)

Hypertriglyceridemia

United States
Oregon Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Evaluating an Online Parenting Support System Disseminated by Pediatric Practices

Attention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Child Disruptive Behavior Disorders

United States
Bristol-Myers Squibb

Completed

An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants

Healthy Participants

United Kingdom, Netherlands

Search clinical trials for: Placebo for Hepar-P

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations